name: Keep supplemental oxygen and equipment for intubation or tracheostomy readily available.


name: Assess effectiveness and placement of airway.


name: Assess patient's response to airway; restrain if necessary.


name: Teach patient or significant other to care for airway (consistent with ability).


name: Include airway care, maintenance in discharge plan.


name: Note centimeter level of endotracheal tube at lip level.


name: Provide care for tracheostomy or endotracheal tube.


name: Change oral endotracheal tube side to side.


name: Maintain endotracheal tube or tracheostomy cuff pressure greater than 14 millimeters mercury but less than 20 millimeters mercury.


name: Keep spare tracheostomy tube at bedside.


name: Extubate patient as indicated or ordered.


name: Provide care related to mechanical ventilation.


name: Monitor ventilator settings, function, alarm system.


name: Utilize CPAP mechanical ventilation as indicated or ordered.


name: Follow protocol for management of patient with continuous pulse oximetry.


name: Follow protocol for management of the patient requiring oxygen therapy.


name: Follow the protocol for the infant in an oxygen hood.


name: Follow protocol for management of the patient with a chest tube.


name: Follow protocol for care of the patient experiencing pleural effusion.


name: Follow protocol for care of the patient with inhalation injury.


name: Follow protocol for pulmonary care of the spinal cord injured patient in rehabilitation.


name: Follow protocol for management of patient in respiratory distress.


name: Follow protocol for management of the patient with acute bronchospasm.


name: Follow protocol for management of the patient with an artificial airway.


name: Follow protocol for management of patient with an endotracheal tube.


name: Follow protocol for management of the patient with mechanical ventilation.


name: Follow protocol for management of the critically ill patient with mechanical ventilation (acute).


name: Follow protocol for management of the non-critically ill patient with mechanical ventilation (non-acute).


name: Follow protocol for management of the patient with CPAP mechanical ventilation.


name: Follow protocol for management of the patient receiving nocturnal nasal positive pressure ventilation (NNPPV).


name: Follow protocol for weaning the patient from mechanical ventilation.


name: Follow protocol for discharge planning of ventilator dependent patients.


name: Follow protocol for management of the patient with a tracheostomy.


name: Follow the protocol for the patient having thoracic surgery.


name: Follow the interdependent protocol and the patient care plan for the post thoracotomy patient.


name: Follow protocol for care of pneumonectomy patient.


name: Follow protocol for management of the patient post lung transplant.


name: Follow protocol for care of the pre and post lung biopsy patient having undergone lung transplantation.


name: Follow protocol for care of the patient undergoing bronchoscopy at the bedside.


name: Follow protocol for care of the pediatric out-patient post-bronchoscopy in the Surgical Admission Suite.


name: Implement patient education plan for chronic obstructive pulmonary disease (COPD).


name: Implement patient education plan for patient with asthma.


name: Implement patient education plan for cystic fibrosis.


name: Implement patient education plan for bronchoscopy.


name: Implement patient education plan for tracheostomy.


name: Implement patient education plan for inhalation injury.


name: Implement patient education plan for pediatric patient with apnea monitor.


name: Implement patient education plan for infant with bronchopulmonary dysplasia.


name: Implement patient education plan for patient with nose and sinus surgery.


name: Role of Family Relationships in Patient Care


name: Contact family to gather information and establish rapport.


name: Allow family to spend time with patient.


name: Involve family in patient's care and teaching.


name: Encourage family activities as much as possible.


name: Address sexuality concerns of patient or significant other.


name: Assess factors surrounding altered sexuality.


name: Provide appropriate educational or counseling resources related to sexuality: such as sexually transmitted diseases, disability.


name: Assess communication abilities and limitations.


name: Provide simple, direct commands, demonstrations, gestures.


name: Assist communication by sentence completion.


name: Provide supplies to facilitate communication.


name: Label intercom system at nurses station to note patient's inability to speak.


name: Promote restoration of verbal communication.


name: Consult speech therapist; encourage patient's participation in speech therapy.


name: Follow protocol for management of the patient with aphasia.


name: Follow protocol for management of the patient with expressive aphasia.


name: Implement patient education plan for safer sex.


name: Assess for conditions which pose a risk to safety.


name: Assess for the presence of sensory deficits.


name: Examine infant or child for signs and symptoms of previous injury.


name: Assess patient and family knowledge of safety precautions.


name: Protect patient from injury to self or others.


name: Supervise patient closely or conduct security checks as needed (such as at all times, while smoking, etc.)


name: Institute precautions as needed (such as, seizure, suicide, etc.).


name: Assess need for additional staff for clinical emergencies (such as, Call to Assist, Code, etc.).


name: Restrain or seclude patient, using least restrictive means or setting, as ordered.


name: Apply protective devices as needed, such as, helmet, splints, arm sling, etc.


name: Remove from environment sharp or blunt objects that could be used to injure patient or others.


name: Instruct patient or family in regard to safety issues or restrictions.


name: Post sign regarding safety precautions at patient bedside as needed.


name: Identify patient by an armband that includes patient name.


name: Feed or assist as needed for all meals; monitor for problems related to swallowing difficulties.


name: Observe and document difficulty swallowing.


name: Consult speech therapy for difficulties swallowing.


name: Position after feeding to minimize risk of aspiration from regurgitation.


name: Dispose of needles and syringes according to policy.


name: Provide special nurse or doctor to transport patient as needed.


name: Use appropriate safety precautions for infants and children.


name: Use only manual beds in the pediatric unit.


name: Keep sharp objects out of children's reach at all times.


name: Maintain supervision of children in the play room.


name: Use bubble tops for cribs of active toddlers.


name: Close and lock all windows on the pediatric units.


name: Do not allow parents to prop bottle when the infant is in the crib.


name: Orient patient to nurse call system; keep bell in reach at all times.


name: Orient patient or family to hospital and or room environment.


name: Orient patient or family to over-bed lighting system.


name: Orient patient or family to bed controls.


name: Orient patient or family to use of kitchen facilities.


name: Place objects patient needs (bedside table, light, TV, telephone, etc.) in easy reach, according to patient's positioning needs.


name: Assure use of non-slip slippers when patient is out of bed.


name: Use enough personnel when moving patient.


name: Keep patient's bed in low position when unattended.


name: Maintain side rails according to policy.


name: Use precautions with equipment according to policy.


name: Use only electrical devices properly grounded and approved by the responsible department (Physical Plant, Engineering Services, etc.)


name: Assess and report electrical hazards to the responsible department (Physical Plant, Engineering Services, etc.)


name: Keep at bedside special equipment needed for safety.


name: Maintain readiness and accessibility of emergency equipment.


name: Follow protocol for prevention of suicide.


name: Follow protocol for the management of patients at high risk for falls.


name: Follow protocol for management of the psychiatric patient at risk of falling.


name: Follow protocol for patient in seclusion.


name: Follow protocol for the management of the patient in restraints.


name: Follow protocol for the management of allergic reactions.


name: Implement patient education plan for drug overdose.


name: Implement patient education plan for orientation of patient or family.


name: Assess ability to perform activities of daily living or self-care.


name: Assess impact of sensory or motor deficits on ability to perform ADL's.


name: Promotion of Activities of Daily Living (ADL's)


name: Assist patient to resume activities of daily living (ADL's).


name: Provide ample time for patient to do self-care activities.


name: Provide instruction for effective oral hygiene.


name: Provide instruction for effective personal hygiene.


name: Assist with adapting activities of daily living (ADL's) to sensory or motor deficits.


name: Assist as needed with basic hygiene, bathing, dressing.


name: Assess for, and obtain occupational therapy consult.


name: Follow recommendations from occupational therapist related to activities of daily living (ADL's).


name: Follow protocol for the patient unable to perform activities of daily living (ADL's).


name: Follow protocol for management of psychiatric patient unable to perform activities of daily living (ADL's).


name: Implement patient education plan for self-catheterization.


name: Promote patient's self-esteem by establishing trusting relationships.


name: Assist patient in acceptance of altered body image.


name: Encourage patient and family to look at altered body parts.


name: Be truthful and convey acceptance of altered body appearance.


name: Encourage patient and family to discuss feelings related to altered appearance.


name: Follow protocol for care of the patient experiencing acute body image disturbance.


name: Assess patient's beliefs and attitudes about pain and pain relief.


name: Assess and identify sources of patient discomfort.


name: Administer medications to increase comfort.


name: Premedicate patient for comfort related to procedure or therapy.


name: Utilize non-pharmacological comfort measures.


name: Teach patient or significant other about pain, pain relief.


name: Work with patient to develop a pain management plan.


name: Include pain management in discharge planning.


name: Provide appropriate visual stimulation for patient with limited visual field.


name: Position self within patient's view to talk, and encourage others to do so.


name: Place objects of interest within patient's view.


name: Assure appropriate sensory stimulation; auditory, visual, tactile, vestibular, olfactory.


name: Assist patient in avoiding over-stimulation.


name: Provide care related to sensory or motor deficits.


name: Monitor symmetry of sensory or motor function of extremities.


name: Follow protocol for management of the patient with acute pain.


name: Implement patient education plan for patient taking oral pain medication for pain control.


name: Implement patient education plan for patient with outpatient cataract surgery.


name: Identify potential risk factors for skin breakdown.


name: Inspect skin of entire body; document significant changes.


name: Inspect skin pressure points before and after sitting and with turning; document significant changes.


name: Assess perianal area for skin breakdown.


name: Determine percentage and depth of burns by means of clinical appearance.


name: Notify physician of changes in skin integrity.


name: Assess patient or family knowledge of risk factors and prevention measures related to skin breakdown.


name: Provide device to minimize skin breakdown.


name: Institute topical therapy as needed or ordered to maintain or restore skin integrity.


name: Administer Lacrilube or artificial tears as indicated.


name: Avoid excessive use of tape; use duoderm or Montgomery straps as needed.


name: Assess effectiveness of topical therapy and modify care as indicated.


name: Have patient wear shoes for specified times each day.


name: Instruct patient or family regarding prevention and treatment of skin breakdown.


name: Instruct patient or family on risk factors for skin breakdown.


name: Instruct patient or family on rationale of pressure relief.


name: Instruct patient or family on measures to reduce shearing, friction and moisture on patient's skin.


name: Note dimensions and depth of pressure ulcer.


name: Note presence of granulation tissue or epithelialization.


name: Note presence or absence of sinus tract formation.


name: Note presence or absence of necrotic tissue, slough, eschar.


name: Promote maintenance or restoration of integrity of oral mucosa.


name: Administer oral care, with adjustments to patient needs.


name: Assess for potential or actual stomatitis.


name: Note oral cavity condition or potential for alteration and any changes that may occur.


name: If bleeding occurs with brushing teeth or flossing gums, discontinue, and use a soft cleanser.


name: Use soft nylon bristle toothbrush or toothette which is soaked in warm water before use and rinsed in warm water during use.


name: Keep dentures out except at meal time, as tolerated.


name: Assess condition of wound, surrounding tissue.


name: Observe for and report any swelling, hematoma, or fistula.


name: Observe and document appearance of skin or muscle flap.


name: Instruct patient to notify nurse if any bleeding occurs.


name: Observe for leakage at suture line or Kyle leak.


name: Document burn or wound appearance and notify physician of any changes.


name: Obtain Polaroid photograph of wounds and place in chart.


name: Prevent or detect early signs of infection to surgical incision or wound.


name: Assess incision or wound for redness, swelling, drainage.


name: Treat impending infection early and appropriately.


name: Notify physician of signs of impending infection.


name: Monitor and cleanse all drainage tubes and catheter sites.


name: Provide appropriate treatment for each wound stage.


name: If no drainage to surgical incision, leave open to air; if drainage, replace dry sterile dressing.


name: Cleanse incision or wound with soap and water.


name: Cleanse incision or wound with recommended solution.


name: Demonstrate methods of incisional support.


name: Assess for compliance with patch and shield to operative eye.


name: Provide specific care for electrical injury or chemical burn.


name: Remove all clothing, brush away solid material.


name: Flush exposed skin with copious amounts of cool water, use eyelid retractors if needed, and utilize appropriate neutralizing agent if indicated.


name: Debride loose tissue with sterile instruments during irrigation.


name: Dress with pluronic on coarse mesh gauze (fine mesh to face, hands, feet, and perineum).


name: Leave donor site wrapped in Xeroform for 24 hours post surgery, then remove outer dressing.


name: Leave Biofrane site wrapped for 24 hours.


name: Allow Xeroform or Biofrane to fall off on its own, then keep skin moist with Eutracream.


name: Check splints for proper fit; readjust as necessary.


name: Keep splints on at all times except during exercise, eating, or bathing.


name: Debride wounds and wash with Shurcleanse.


name: Apply topical anti-microbial agent and gauze as indicated and dress occlusively.


name: Wrap new graft with Vaseline gauze for 2-3 days post graft takedown.


name: Clean graft edges with daily gentle debridement of nonadhered skin.


name: Avoid mechanical and chemical trauma to freshly grafted areas.


name: Assess trauma to torso; chest and abdomen.


name: Monitor for signs, symptoms of gastrointestinal bleeding.


name: Monitor all stools, emesis, or gastric drainage for guaiac.


name: Clean around nasal balloon and check for any areas of pressure.


name: Follow protocol for care of a patient on a specialty bed.


name: Follow protocol for the management of the patient with a Jackson-Pratt drain.


name: Follow protocol for management of the patient with a drainage tube (T-tube).


name: Follow protocol for management of the patient with an alteration in skin integrity.


name: Follow protocol for the adult patient at risk for developing skin impairment due to pressure or irritation.


name: Follow protocol for the pediatric patient at risk for developing skin impairment due to pressure or irritation.


name: Follow protocol for management of the patient with an intravenous extravasation.


name: Follow protocol for management of the patient with an alteration in skin integrity requiring a skin graft.


name: Follow protocol for patient with split-thickness skin graft (STSG) after takedown.


name: Follow protocol for care of the patient with a muscle or skin graft.


name: Follow the protocol for the pediatric patient with an Abdominal Silo.


name: Follow the protocol for the management of the patient with Stomatitis.


name: Follow protocol for skin management for the spinal cord injured patient in rehabilitation.


name: Follow protocol for stump care management: Patient with prosthesis fitting and gait training (PFGT) or Rehabilitation Phase.


name: Follow protocol for stump care management: Patient with prosthesis fitting and training (upper extremity) or Rehabilitation Phase.


name: Implement patient education plan for patient at high risk for impaired skin integrity.


name: Implement patient education plan for patients with potential or actual alteration in tissue integrity.


name: Implement patient education plan for repair of decubitus ulcer of sacrum, trochanter, or ischium.


name: Implement patient education plan for patient with wound care or dressing changes.


name: Implement patient education plan for the patient with a drainage tube (T- tube) or a Jackson-Pratt drain.


name: Implement patient education plan for the patient with a skin flap.


name: Implement patient education plan for the patient with a burn injury.


name: Implement patient education plan for wound care at home.


name: Implement patient education plan for patient with breast biopsy.


name: Monitor tissue perfusion of extremities and report changes as indicated.


name: Assess and monitor skin color and temperature.


name: Monitor pulses of affected extremities utilizing Doppler as needed.


name: Monitor and record SaO2 of circumferentially burned extremities.


name: Notify physician of SaO2 are less than 90%, decreasing or absent pulses, or increasingly sluggish capillary refill.


name: Discuss with physician possible need for escharotomy or fasciotomy.


name: Prepare patient and family for escharotomy or fasciotomy if indicated.


name: Monitor for edema secondary to increased cellular permeability.


name: Assess neurovascular status; color, temperature, movement and sensation.


name: Perform neurovascular checks to upper extremities.


name: Perform neurovascular checks to lower extremities.


name: Perform neurovascular checks to affected extremity.


name: Teach patient and family to perform neurovascular checks.


name: Institute thermal therapy as ordered or indicated.


name: Apply ice or cool compress as ordered or indicated.


name: Apply moist or dry heat as ordered or indicated.


name: Assess tissue perfusion of transplanted kidney.


name: Monitor urine output hourly while Foley catheter is in place.


name: Follow protocol for the patient requiring close extremity observation due to neurovascular impairment from injury, disease or surgery.


name: Monitor for previous and current patterns of voiding.


name: Monitor frequency and volume of voiding.


name: Promote and assist with return to normal urinary function.


name: Provide access to bathroom or bedpan or urinal.


name: Cleanse catheter and surrounding tissues.


name: Teach patient and family care related to Foley catheter.


name: Follow generic bladder management protocol related to spinal cord injured persons in rehabilitation.


name: Follow protocol for management of the patient requiring a Foley catheter.


name: Follow protocol for management of the patient requiring a Texas catheter.


name: Follow protocol for management of patients with suprapubic, ureteral or nephrotomy catheters.


name: Follow protocol for bladder management (not related to spinal cord injury).


name: Implement patient education plan for patient with radical retropubic prostatectomy.


name: Implement patient education plan for patient with suprapubic catheter placement.


name: Implement patient education plan for pediatric patient with suprapubic catheter placement.


name: Implement patient education plan for pediatric patient with hypospadias repair.


name: Implement patient education plan for pediatric patient with orchiopexy.


name: PRE- OR INTRA- OR POST-PROCEDURE COMPONENT


name: Perform multi-system nursing assessment.


name: Conduct complex admission screening or assessment.


name: Conduct complex discharge screening or assessment.


name: Perform an initial and ongoing assessment; pre-, intra-, and post-procedure or surgery.


name: Assess the patient's response to interventions and adjust care accordingly.


name: Consult physician or service as indicated.


name: Teach patient or significant other(s) about procedure using appropriate means and media.


name: Provide educational materials: handouts, booklets, tapes, etc.


name: Emphasize importance of patient's or significant other's participation.


name: Teach what to expect before, during, after procedure.


name: Teach skills, use of equipment related to procedure.


name: Assess learning; reinforce teaching as needed.


name: Encourage questions; provide clear answers.


name: Educate patient and or family related to expected results.


name: Prepare patient for procedure, with respect for patient rights.


name: Assess patient's knowledge and expectations of procedure.


name: Assess patient's experience with surgery, anesthesia, this procedure.


name: Explain and ensure dietary restrictions as ordered.


name: Administer medications, enemas, skin preparation, intravenous infusion fluids, etc. as ordered.


name: Complete pre-operative or pre-procedure checklist.


name: Facilitate safety and effectiveness of procedures.


name: Collaborate with physician as needed: Assist, consult, report adverse signs and symptoms, obtain orders.


name: Prepare and monitor operating or procedure room environment.


name: Maintain lines, tubes, catheters used to administer substances to patient or to monitor patient condition.


name: Provide care related to patient transfer or transfer patient.


name: Monitor safety and effectiveness of regional anesthesia.


name: Assess patient vital signs before, during and after administration of regional anesthesia.


name: Observe for adverse effects of anesthesia, report findings.


name: Assess effect of blood patch on pain of spinal headache.


name: Follow the protocol for the preadmission assessment center visit.


name: Follow protocol for care of the patient who is having a surgical procedure (preoperative).


name: Follow protocol for care of the pre-operative thoracic cardiovascular surgery (TCV) patient.


name: Follow protocol for admission of a patient to the surgical admission suite (SAS) and Breast Center. (breast biopsy)


name: Follow the interdependent protocol and patient care plan for the adult pre operative and general surgery patient.


name: Follow protocol for care of the intraoperative patient.


name: Follow protocol for care of the patient who had a surgical procedure (postoperative).


name: Follow protocol for the patient with monitored conscious sedation for minimally depressing the level of consciousness while providing analgesia for procedure.


name: Follow protocol for patient who has had monitored sedation.


name: Follow the protocol for the management of the patient in a Post Anesthesia Care Unit.


name: Follow protocol for post anesthesia patient (general).


name: Follow protocol for the patient who has had regional anesthesia.


name: Follow the protocol for the patient with an epidural catheter.


name: Follow the protocol for the patient who is receiving intrathecal anesthesia.


name: Implement patient education plan for pre-operative teaching.


name: Implement patient education plan for pre-operative ambulatory or outpatient surgery patients.


name: Implement patient education plan for generic Emergency Department patients.


name: Implement patient education plan for admitting generic Emergency Department patients.


name: Implement patient education plan for discharging generic Emergency Department patients.


name: Mobility, exercise, and activity will increase to optimal or return to baseline.


name: Patient's activity tolerance will increase or progress.


name: Patient will conserve energy and avoid fatigue.


name: Patient will utilize orthotic or assistive devices correctly to optimize independence in activity.


name: Patient will attend school as appropriate, when able.


name: Musculoskeletal function will be maintained or restored at best feasible level.


name: Muscle tone will be maintained or restored.


name: Range of motion will be maintained or restored to the level prevailing prior to current illness, injury, or surgery.


name: Patient will maintain correct body alignment.


name: Patient will maintain required positioning and comply with activity restrictions.


name: Patient will recall and follow hip precautions.


name: Immobilization requiring the use of devices or traction will be maintained as ordered.


name: Patient will avoid complications or injury associated with immobility.


name: Patient will acquire mobility via wheelchair.


name: Patient will tolerate progressively extended periods of mobilization to wheelchair without orthostatic hypotension, skin impairments, excessive fatigue, or intolerable discomfort.


name: Patient will be functionally or verbally independent in wheelchair preparation, transfers, and mobilization on the unit.


name: Patient will regain or maintain or progress toward independence in ambulation.


name: Patient will progress toward ambulation with or without assistive devices on level surfaces on the unit.


name: Patient will experience adequate rest and sleep.


name: Patient will demonstrate satisfaction or comfort with level of sleep or rest achieved.


name: Patient will experience uninterrupted 60-90 minute sleep cycles to allow for adequate rest.


name: Patient will incorporate rest periods into daily activity.


name: Patient will regain pre-hospitalization sleep patterns.


name: Normal bowel elimination pattern will be maintained or restored


name: Patient will demonstrate age-appropriate stooling patterns.


name: Patient will resume or maintain optimal gastric motility or pass flatus.


name: Patient will maintain or return to best feasible bowel function within constraints of the disease or surgical procedure.


name: Fluid loss through stools will not be excessive.


name: Bowel incontinence will be rare or absent.


name: Abdominal distension will be minimal or absent.


name: The spinal cord injured (SCI) patient will develop safe and effective bowel management routines (which will assure adequate emptying of the colon, minimize incontinent emptying of the bowel, avoid constipation, avoid mucosal irritation or injury, and avoid dysreflexic episodes).


name: Patient will maintain optimal gastrointestinal functioning.


name: Patient will experience adequate and comfortable digestive processes.


name: Patient will experience minimal nausea and vomiting.


name: Patient will exhibit evidence of adequate cardiac output.


name: Fetal heart rate will remain within normal patterns.


name: Patient will develop optimal cardiac tolerance.


name: Patient will maintain or achieve hemodynamic stability.


name: Cardiac electrophysiology will return to normal.


name: Patient will demonstrate resolution of electrocardiogram (EKG, ECG) changes.


name: Normal sinus rhythm will be maintained or restored.


name: Patency of vascular system will be maintained.


name: Patient will remain free of pulmonary emboli.


name: Patient will remain free of deep vein thrombosis.


name: Patient will experience minimal circulatory complications or sequelae.


name: Chest X-ray will show no evidence of pulmonary edema.


name: Patient (or family) will verbalize understanding of need for non-invasive monitoring.


name: Patient (or family) will verbalize understanding of the need for and method of invasive monitoring.


name: Optimal function of central, arterial, or venous lines will be maintained.


name: Patient will maintain or return to best feasible mental status and level of consciousness.


name: Patient will demonstrate increased orientation to current environment.


name: Patient will demonstrate behavior consistent with cognitive ability.


name: Patient will remain free from seizure activity.


name: Patient will demonstrate effective and appropriate coping with anxiety or fear.


name: Patient will experience a reduction in anxiety or fear; will exhibit decreasing symptoms of fear.


name: Patient will mobilize personal resources to control anxiety.


name: Patient or significant other will discuss issues related to focus or source of anxiety.


name: Signs & symptoms of psychosis will diminish or resolve.


name: Patient will demonstrate accurate reality testing.


name: Patient will communicate absence of or less bothersome hallucinations, delusions, or paranoid ideation.


name: Patient will not experience hospital-acquired psychosis.


name: Patient or family will demonstrate progress toward effective adjustment and coping strategies.


name: Patient or family will freely communicate feelings to staff.


name: Patient or family will demonstrate acceptance of limitations, knowledge of stress, and awareness of new coping mechanisms.


name: Patient or family will express concerns and seek resolution appropriately.


name: Patient will decrease use of denial as a defense mechanism.


name: Patient will develop effective management of guilt feelings.


name: Patient will demonstrate brief delays in gratification without agitation.


name: Patient will demonstrate increased impulse control.


name: Patient will effectively manage stressors.


name: Patient will demonstrate ability to solve problems.


name: Patient will demonstrate improved time-management skills.


name: Patient will identify consequences of actions.


name: Patient will identify negative consequences of substance abuse.


name: Patient or family will validate need for help.


name: Patient will demonstrate an appropriate range of affect.


name: Patient or family will demonstrate appropriate responses to loss.


name: Patient will remain calm and exhibit decreased signs of agitation.


name: Social and emotional development will remain within or progress toward the optimal within the limits of health, illness, and treatment.


name: Patient will demonstrate behavior commensurate with developmental level.


name: Developmental delays will be avoided or minimized.


name: Patient will demonstrate diversional activity commensurate with ability and interest.


name: Patient or family coping will be enhanced by interaction with therapeutic milieu.


name: Patient or family will not engage in behaviors disruptive to the milieu or personally embarrassing.


name: Patient or family will identify own progress in improved interpersonal skills.


name: Patient or family will demonstrate trust in the nurse-patient relationship.


name: Normal fluid volume and electrolytes will be maintained or restored.


name: Patient will maintain or restore compartmental fluid balance, including adequate circulatory volume.


name: Patient will maintain or restore adequate but not excessive hydration.


name: Patient intake and output will equalize.


name: Imbalance of fluids or electrolytes will be avoided or minimized.


name: Patient will exhibit minimal signs or symptoms of hypovolemia.


name: Patient will exhibit minimal signs or symptoms of hypervolemia.


name: Patient's weight will change to reflect restoration of fluid balance.


name: Patient or family will demonstrate knowledge and ability to manage health care with professional assistance or supervision.


name: Patient or family will demonstrate understanding of condition, treatment, and plan of care.


name: Patient or family will verbalize knowledge of functional limitations.


name: Patient or family will demonstrate knowledge and ability to manage continuing health care needs after discharge.


name: Patient or family will demonstrate understanding of home care.


name: Patient or family will successfully perform return demonstration of required skills.


name: Patient or family will be able to administer medications safely.


name: Patient or family will demonstrate knowledge of appropriate health behaviors.


name: Patient or family will demonstrate motivation to engage in appropriate health behaviors.


name: Patient or family will acknowledge the need for diagnostic procedures or tests, seeking information and participating in preparing for and performing procedures or tests.


name: Patient or family will acknowledge the need for the therapeutic regimen, seeking information and exercising control, as appropriate, in carrying out the regimen.


name: Patient will express trust in treatment plan.


name: Patient or family will describe a plan for or will demonstrate health behaviors conducive to good health.


name: Patient will not exhibit signs of infection.


name: Full thickness burns will have wound bacterial counts of less than 105.


name: Patient will remain free of nosocomial infection.


name: Patient or family will verbalize signs and symptoms of infection.


name: Patient immunizations will be up to date.


name: Patient will understand and assist with isolation restrictions.


name: Patient will understand and assist with respiratory isolation.


name: Patient will be at decreased risk for secondary pulmonary infection.


name: Patient will maintain rejection-free state.


name: Acute rejection will be diagnosed early and treated.


name: Patient will derive maximum benefit from medications administered.


name: Medication blood levels will be maintained at therapeutic levels.


name: Medications will be administered safely and according to policy.


name: Patient will experience minimal drug toxicity.


name: Patient will remain free of or recover fully from serious side effects or untoward reaction to medications.


name: Patient will derive maximum benefit from blood products administered.


name: Blood products are administered safely and according to policy.


name: Patient will remain free of or recover fully from serious side effects or untoward reactions to blood products administration.


name: Patient will maintain or return to optimal organ function as evidenced by appropriate lab values.


name: Patient will have optimal chemistry lab values.


name: Coagulation factors will remain within, or return to, appropriate levels.


name: Serum lipid levels will improve or stabilize to normal limits.


name: Patient will have appropriate glucose level.


name: Patient will remain free of signs or symptoms of blood glucose alteration.


name: Urine will test negative for glucose or ketones.


name: Patient with bleeding disorder or anticoagulant therapy will not have excessive bleeding.


name: Patient will not have evidence of active bleeding.


name: Patient will display minimal signs or symptoms of thrombocytopenia.


name: Patient will avoid activities that increase the risk of bleeding.


name: Patient will remain free from or recover fully from, signs or symptoms of tetany.


name: Ascites will stabilize, reduce, or resolve.


name: Nutritional status will be maintained to meet body requirements.


name: Body weight will be consistent with age, height, and build.


name: Patient will maintain a baseline nutritional status.


name: Patient will have minimal signs or symptoms of nutritional deficits.


name: Patient will have a positive calorie balance.


name: Patient will maintain or return to a positive nitrogen balance.


name: Weight loss will not exceed 10% of body weight.


name: Patient will have decreased catabolic metabolism.


name: Patient will consume a diet that includes the components or restrictions necessary for health.


name: Patient will tolerate progressive advancement of diet.


name: Patient or infant will demonstrate healthy appetite and satiety.


name: Infant will feed on demand, retaining breast milk or formula.


name: Enteral or parenteral feedings will meet body requirements.


name: TPN will be administered safely and according to policy.


name: Patient will tolerate tube feedings, without high residuals.


name: Vital signs will be within normal limits.


name: Blood pressure will be maintained or restored within normal limits.


name: Patient will develop tolerance of low baseline blood pressure (relative to pre-injury norms).


name: Patient will maintain systolic blood pressure >100.


name: Body temperature will remain within or return to normal or desired range.


name: Physiologic homeostasis will be maintained or restored.


name: Patient will have stable or improved body systems function.


name: Patient will achieve physical wellness or ability to prevent exacerbation of symptoms in response to stress.


name: Optimal acid or base balance will be restored or maintained.


name: Patient will avoid or recover from dysreflexic episodes.


name: Patient will recognize and do, or instruct others to do, the interventions necessary to minimize the risk of autonomic dysreflexia.


name: Patient will do, instruct others to do, the interventions necessary to aid in the resolution of dysreflexic episodes.


name: Patient will achieve or maintain freedom from chemical dependency.


name: Patient will demonstrate awareness of actual or potential chemical dependency and seek additional information or treatment as appropriate.


name: Patient will be free of non-prescription mood-altering medications by discharge.


name: Patient will tolerate detoxification safely, with minimal complications. (e.g.: seizures, DT's, etc.)


name: Patient will return to baseline health status.


name: Optimal neurological function will be maintained or restored.


name: Patient will maintain stable intracranial pressure.


name: Patient will achieve optimal neurosensory or neuromuscular function.


name: Maternal or fetal risks will be minimized.


name: Maternal health and fetal wellbeing will be optimized through regular prenatal care.


name: Mother and fetus will remain healthy throughout the term of gestation.


name: Mother and infant will experience safe and successful birth.


name: Mother or family will participate effectively in birthing process.


name: Mother or family will experience minimal, and recover fully from, adverse reactions or serious complications of the birthing process.


name: Mother will experience optimal involution process postpartum.


name: Infant wellbeing will be optimized throughout postnatal period.


name: Optimal respiratory function will be maintained or restored to meet body requirements.


name: Effective breathing pattern will be maintained or resumed.


name: Patient will demonstrate adequate respiratory volumes.


name: Patient will maintain adequate respiratory rate without dyspnea, with pO2 of 80-100 and O2 saturation greater than 90%.


name: Patient will maintain or improve ventilatory rate.


name: Natural or artificial airway patency will be maintained or restored.


name: Patient will adequately clear secretions.


name: Patient will have clear or improved breath sounds.


name: Patient will maintain adequate gas exchange to meet body requirements.


name: Blood gases will be within normal limits within constraints of condition.


name: Patient will demonstrate optimal gas exchange for condition.


name: Patient will not demonstrate signs and symptoms of air hunger, restlessness or cyanosis.


name: Respiratory function will be restored or enhanced through use of ventilator.


name: Patient will tolerate weaning from ventilator.


name: Patient will remain free of aspirations, atelectasis, infiltrates, pneumonia, and pneumothorax.


name: Chest x-ray will evidence stabilization or improvement in condition.


name: Lung expansion will be maintained or restored through proper use of pleural evacuation (chest tube).


name: Patient will remain free of inhalation injury.


name: Patient will develop effective methods of communication and interaction.


name: Patient will show increased tolerance for interaction with others.


name: Patient will identify support systems conducive to sobriety.


name: Patient will obtain adequate social interaction.


name: Optimal family process will be maintained or restored.


name: Family will actively participate in patient's care.


name: Patient or family will identify effects of addiction on the family process.


name: Patient or significant other will express acceptance of changes in sexual function.


name: Patient or significant other will identify personally satisfying and mutually acceptable means of sexual expression.


name: Parents will be able to interact and respond in developmentally appropriate ways to their infant or child.


name: Child or parent bonding will be maintained or strengthened.


name: Parent(s) will express reduced feelings of guilt related to child's illness, injury, hospitalization, or disability.


name: Patient or family will demonstrate awareness of risks to safety.


name: Patient or family will acknowledge the need for and maintain safety precautions.


name: Patient or family will describe modifications to home environment needed for safety.


name: Patient or family will make modifications to home environment needed for safety.


name: Patient will remain free from harm or accidental injury.


name: Patient will not suffer injury related to diminished sensation and proprioception.


name: Patient will remain free of injury related to decreased level of consciousness.


name: Patient environment will be free of hazards.


name: Patient will not be exposed to electrical hazards.


name: Patient will not be exposed to allergens.


name: Safety risks will be minimized through special safety measures.(e.g., for infants, children, those with sensory deficits).


name: Special safety equipment will be available as needed.


name: Patient will experience the least restrictive degree of restraint or seclusion necessary for safety.


name: Patient or family will identify risks of violence in the home or community.


name: Patient or family will describe actions to minimize the risk of violence.


name: Patient or family will describe appropriate actions to take if violence occurs.


name: Patient will independently perform self care at highest functional level within parameters of condition.


name: Patient will demonstrate pre-admission or better level of functioning with activities of daily living (ADL's).


name: Patient will be able to direct others in all aspects of self-care.


name: Patient will accept assistance with activities of daily living(ADL's) when needed.


name: Patient's self-esteem will be maintained or restored.


name: Patient will demonstrate trust in self and others.


name: Patient or family will adapt to body changes, and their impact on lifestyle and future.


name: Patient will look at and acknowledge change in appearance.


name: Patient will identify and communicate thoughts and feelings regarding physical change or altered body image.


name: Patient will verbalize realistic perception of body changes.


name: Sources of pain and contributing factors will be identified.


name: Factors which exacerbate pain will be minimized.


name: Patient will verbally or nonverbally demonstrate increased comfort or tolerable level of pain.


name: Patient will rate pain on a scale or system defining level of comfort or pain.


name: Patient will express relief from discomforts other than pain.


name: Patient will identify and communicate an absence of pain.


name: Sensory alterations will be identified, and adverse effects minimized.


name: Patient will adapt to sensory alterations or deficits.


name: Patient will experience appropriate sensory stimulation in context of condition.


name: Tissue integrity will be maintained or promoted.


name: Patient will maintain a moist, intact oral mucus membrane.


name: Patient will progressively develop tolerance to pressure on recumbent surfaces and will maintain skin integrity.


name: Patient or family will verbalize understanding of risk factors and prevention of skin breakdown.


name: Risk factors for skin breakdown will be minimized or eliminated.


name: Skin impairment(s) will progress toward resolution.


name: Wound will heal without complications.(e.g.: excessive or recurrent bleeding, dehiscence, breakdown, swelling, drainage, hematoma, fistula, etc.)


name: Wound or burn will heal with minimal scarring or keloid formation.


name: Patient will have complete healing of bone fractures.


name: Integrity of internal mucous membranes will be maintained or restored.


name: Patient will maintain gastric pH of 5 to 7.


name: Patient will maintain gastric pH of 7 to 8.


name: All stools or gastric drainage will be guaiac negative.


name: Patients with partial thickness burns will heal in 2-3 weeks without grafting.


name: Patient will experience minimal losses post-trauma.


name: Optimal tissue perfusion will be maintained or restored.


name: Patient will maintain adequate tissue perfusion to areas affected by disease or treatment as evidenced by presence of peripheral pulses, brisk capillary refill.


name: Optimal neurovascular status will be maintained or restored.


name: Optimal organ tissue perfusion will be maintained or restored.


name: Patient will maintain adequate urine output (30-60 milliliters per hour for adults, 1 milliliter per kilogram per hour for children).


name: Patient will maintain an adequate urine output for post-traumatic burn patient (75-100 milliliters per hour).


name: Patient's neurological response will be at or above admission baseline.


name: Patient will maintain best feasible urinary function within constraints of disease, surgery, etc.


name: Patient will void spontaneously after surgery.


name: Patient will adapt to altered urinary function and use of assistive devices.


name: Optimal urine specific gravity will be maintained or restored.


name: Patient will develop safe and effective bladder management routines, minimizing urinary retention and maximizing continence.


name: Spinal cord injured patient will develop safe and effective bladder management routine, assuring bladder emptying, maintaining tone, avoiding distension, and avoiding dysreflexia, infection.


name: Patient will experience safe and effective surgery or procedure.


name: Patient will be physically prepared for procedure or surgery.


name: Patient will be psychologically prepared for upcoming procedure.


name: Patient or family will demonstrate appropriate knowledge of surgery or procedure and related factors.


name: Patient will avoid or recover fully from complications from surgery or procedure.


name: Patient will have minimal postoperative bleeding.


name: Patient will have full recovery from anesthesia.


name: Patient will have full recovery from general anesthesia.


name: Patient will have full recovery from regional anesthesia.


name: Patient will have full recovery from monitored sedation.


name: Social isolation caused by infection control precautions


name: Grieving anticipated or actual loss of pregnancy, and or loss of "perfect" child


name: Grieving loss of body part, function, or appearance


name: Family or significant other's grieving anticipated loss of pregnancy or loss of "perfect" child


name: Family or significant other's grieving for patient's loss of body part, function, or appearance


name: Family or significant other's anticipatory grieving for dying patient


name: Alteration in physical regulation caused by pregnancy


name: Inability to speak or understand English


name: Assessment: Medications and Blood Products


name: Assessment: Pre- or Intra- or Post-Procedure


name: Patient Education Plans: Bowel Elimination


name: Patient Education Plans: Health Behavior


name: Patient Education Plans: Medications and Blood Products


name: Patient Education Plans: Physical Regulation


name: Patient Education Plans: Role Relationship


name: Patient Education Plans: Sensation, Pain and Comfort


name: Patient Education Plans: Tissue Integrity


name: Patient Education Plans: Urinary Elimination


name: Patient Education Plans: Pre- or Intra- or Post-Procedure


name: Excision or destruction of lesion or tissue of eyelid


name: Evacuation of retained product of conception


name: Repair of posterior cruciate ligament of knee joint


name: Creatinine renal clearance/1.73 sq M:ArVRat:12H:Urine+Ser/Plas:Qn


name: Deprecated Monosialoganglioside GM1 Ab.IgA in serum


name: Resistivity index:VelRto:Pt:Cerebral artery anterior^Fetus:Qn:US.doppler


name: (Aspergillus fumigatus+Aspergillus niger) Ab.IgE:ACnc:Pt:Ser:Qn


name: Candida albicans immune complex:ACnc:Pt:Ser/Plas:Qn


name: Foeniculum vulgare fresh Ab.IgE:ACnc:Pt:Ser:Qn


name: Foeniculum vulgare seed Ab.IgE:ACnc:Pt:Ser:Qn


name: Horse serum proteins Ab.IgE:ACnc:Pt:Ser:Qn


name: Cucurbita pepo seed Ab.IgE:ACnc:Pt:Ser:Qn


name: Rabbit serum proteins Ab.IgE:ACnc:Pt:Ser:Qn


name: Rabbit urine proteins Ab.IgE:ACnc:Pt:Ser:Qn


name: Brassica napus pollen Ab.IgE:ACnc:Pt:Ser:Qn


name: Bovine serum albumin Ab.IgE:ACnc:Pt:Ser:Qn


name: Swine urine proteins Ab.IgE:ACnc:Pt:Ser:Qn


name: Basophils/100 leukocytes:NFr:Pt:Body fld:Qn:Manual count


name: Basophils/100 cells:NFr:Pt:Bone mar:Qn:Manual count


name: Eosinophils/100 leukocytes:NFr:Pt:Body fld:Qn:Manual count


name: Eosinophils/100 cells:NFr:Pt:Bone mar:Qn:Manual count


name: Deprecated Normoblasts Basophilic/100 cells in Bone marrow by Microscopy


name: Deprecated Normoblasts Orthochromic/100 cells in Bone marrow by Microscopy


name: Deprecated Normoblasts Polychromatophilic/100 cells in Bone marrow by Microscopy


name: Lymphocytes.variant/100 cells:NFr:Pt:Bone mar:Qn:Manual count


name: Lymphocytes.large granular/100 leukocytes:NFr:Pt:Bld:Qn:Manual count


name: Lymphocytes/100 cells:NFr:Pt:Bone mar:Qn:Manual count


name: Macrophages/100 leukocytes:NFr:Pt:Body fld:Qn:Manual count


name: Mast cells/100 cells:NFr:Pt:Bone mar:Qn:Manual count


name: Megakaryocytes/100 cells:NFr:Pt:Bone mar:Qn:Manual count


name: Mesothelial cells/100 leukocytes:NFr:Pt:CSF:Qn:Manual count


name: Mesothelial cells/100 leukocytes:NFr:Pt:Body fld:Qn:Manual count


name: Metamyelocytes/100 cells:NFr:Pt:Bone mar:Qn:Manual count


name: Monocytes/100 cells:NFr:Pt:Bone mar:Qn:Manual count


name: Mononuclear cells/100 leukocytes:NFr:Pt:CSF:Qn:Manual count


name: Myeloblasts/100 cells:NFr:Pt:Bone mar:Qn:Manual count


name: Myelocytes/100 cells:NFr:Pt:Bone mar:Qn:Manual count


name: Myeloid cells/Erythroid cells:NRto:Pt:Bone mar:Qn


name: Neutrophils.band form/100 leukocytes:NFr:Pt:CSF:Qn:Manual count


name: Neutrophils.band form/100 leukocytes:NFr:Pt:Body fld:Qn:Manual count


name: Neutrophils.band form/100 cells:NFr:Pt:Bone mar:Qn:Manual count


name: Neutrophils/100 cells:NFr:Pt:Bone mar:Qn:Manual count


name: Normoblasts.basophilic/100 cells:NFr:Pt:Bone mar:Qn:Manual count


name: Normoblasts.orthochromic/100 cells:NFr:Pt:Bone mar:Qn:Manual count


name: Normoblasts.polychromatophilic/100 cells:NFr:Pt:Bone mar:Qn:Manual count


name: Plasma cells.immature/100 cells:NFr:Pt:Bone mar:Qn:Manual count


name: Plasma cells/100 cells:NFr:Pt:Bone mar:Qn:Manual count


name: Polymorphonuclear cells/100 leukocytes:NFr:Pt:CSF:Qn:Manual count


name: Promyelocytes/100 cells:NFr:Pt:Bone mar:Qn:Manual count


name: Prolymphocytes/100 cells:NFr:Pt:Bone mar:Qn:Manual count


name: Promonocytes/100 cells:NFr:Pt:Bone mar:Qn:Manual count


name: Pronormoblasts/100 cells:NFr:Pt:Bone mar:Qn:Manual count


name: Unspecified cells/100 leukocytes:NFr:Pt:Body fld:Qn:Manual count


name: 17-Hydroxyprogesterone^15M post 250 ug corticotropin IM:MCnc:Pt:Ser/Plas:Qn


name: 17-Hydroxyprogesterone^2nd specimen post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: 17-Hydroxyprogesterone^30M post 250 ug corticotropin IM:MCnc:Pt:Ser/Plas:Qn


name: 17-Hydroxyprogesterone^3rd specimen post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: 17-Hydroxyprogesterone^4th specimen post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: 17-Hydroxyprogesterone^5th specimen post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: C peptide^1.5H post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: C peptide^1H post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: C peptide^2.5H post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: C peptide^2H post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: C peptide^2nd specimen post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: C peptide^30M post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: C peptide^3H post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: C peptide^3rd specimen post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: C peptide^4th specimen post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: C peptide^5H post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: C peptide^5th specimen post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: C peptide^6H post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: C peptide^6th specimen post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: Calcitonin^2nd specimen post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: Calcitonin^3rd specimen post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: Calcitonin^4th specimen post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: Calcitonin^5th specimen post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: Calcitonin^6th specimen post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: Catecholamines^2nd specimen post XXX challenge:MCnc:Pt:Urine:Qn


name: Catecholamines^2nd specimen post XXX challenge:MCnc:Pt:Plas:Qn


name: Catecholamines^3rd specimen post XXX challenge:MCnc:Pt:Plas:Qn


name: Catecholamines^3rd specimen post XXX challenge:MCnc:Pt:Urine:Qn


name: Catecholamines^4th specimen post XXX challenge:MCnc:Pt:Plas:Qn


name: Catecholamines^4th specimen post XXX challenge:MCnc:Pt:Urine:Qn


name: Catecholamines^5th specimen post XXX challenge:MCnc:Pt:Urine:Qn


name: Catecholamines^6th specimen post XXX challenge:MCnc:Pt:Urine:Qn


name: Catecholamines^7th specimen post XXX challenge:MCnc:Pt:Urine:Qn


name: Corticotropin^2nd specimen post XXX challenge:MCnc:Pt:Plas:Qn


name: Corticotropin^3rd specimen post XXX challenge:MCnc:Pt:Plas:Qn


name: Corticotropin^4th specimen post XXX challenge:MCnc:Pt:Plas:Qn


name: Corticotropin^5th specimen post XXX challenge:MCnc:Pt:Plas:Qn


name: Corticotropin^6th specimen post XXX challenge:MCnc:Pt:Plas:Qn


name: Corticotropin^7th specimen post XXX challenge:MCnc:Pt:Plas:Qn


name: Corticotropin^8th specimen post XXX challenge:MCnc:Pt:Plas:Qn


name: Cortisol^10th specimen post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: Cortisol^1H post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: Cortisol^2.5H post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: Cortisol^20M post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: Cortisol^2nd specimen post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: Cortisol^30M post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: Cortisol^3rd specimen post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: Cortisol^4th specimen post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: Cortisol^5th specimen post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: Cortisol^6th specimen post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: Cortisol^7th specimen post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: Cortisol^8th specimen post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: Cortisol^9th specimen post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: DOPamine^2nd specimen post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: DOPamine^3rd specimen post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: DOPamine^4th specimen post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: DOPamine^5th specimen post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: DOPamine^6th specimen post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: DOPamine^7th specimen post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: EPINEPHrine^2H post XXX challenge:MCnc:Pt:Plas:Qn


name: EPINEPHrine^2nd specimen post XXX challenge:MCnc:Pt:Plas:Qn


name: EPINEPHrine^3rd specimen post XXX challenge:MCnc:Pt:Plas:Qn


name: EPINEPHrine^4th specimen post XXX challenge:MCnc:Pt:Plas:Qn


name: EPINEPHrine^5th specimen post XXX challenge:MCnc:Pt:Plas:Qn


name: EPINEPHrine^6th specimen post XXX challenge:MCnc:Pt:Plas:Qn


name: EPINEPHrine^7th specimen post XXX challenge:MCnc:Pt:Plas:Qn


name: Estradiol^3H post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: Estrogen^2nd specimen post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: Follitropin^5th specimen post XXX challenge:SCnc:Pt:Ser/Plas:Qn


name: Follitropin^10M post XXX challenge:SCnc:Pt:Ser/Plas:Qn


name: Follitropin^20M post XXX challenge:SCnc:Pt:Ser/Plas:Qn


name: Follitropin^2nd specimen post XXX challenge:SCnc:Pt:Ser/Plas:Qn


name: Follitropin^3H post XXX challenge:SCnc:Pt:Ser/Plas:Qn


name: Follitropin^3rd specimen post XXX challenge:SCnc:Pt:Ser/Plas:Qn


name: Follitropin^40M post XXX challenge:SCnc:Pt:Ser/Plas:Qn


name: Follitropin^4th specimen post XXX challenge:SCnc:Pt:Ser/Plas:Qn


name: Follitropin^6th specimen post XXX challenge:SCnc:Pt:Ser/Plas:Qn


name: Follitropin^7th specimen post XXX challenge:SCnc:Pt:Ser/Plas:Qn


name: Follitropin^8th specimen post XXX challenge:SCnc:Pt:Ser/Plas:Qn


name: Follitropin^9th specimen post XXX challenge:SCnc:Pt:Ser/Plas:Qn


name: Glucose^10H post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: Glucose^10M post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: Glucose^10M pre XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: Glucose^10th specimen post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: Glucose^11th specimen post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: Glucose^12H post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: Glucose^12th specimen post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: Glucose^13th specimen post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: Glucose^14th specimen post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: Glucose^15M post 50 g lactose PO:MCnc:Pt:Ser/Plas:Qn


name: Glucose^15M post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: Glucose^15M post dose lactose PO:MCnc:Pt:Ser/Plas:Qn


name: Glucose^15th specimen post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: Glucose^1H post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: Glucose^1st specimen post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: Glucose^2.5H post 75 g glucose PO:PrThr:Pt:Urine:Ord:Test strip


name: Glucose^20M post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: Glucose^2H post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: Glucose^2M post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: Glucose^2nd specimen post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: Glucose^3.5H post 75 g glucose PO:PrThr:Pt:Urine:Ord:Test strip


name: Glucose^3.5H post dose lactose PO:MCnc:Pt:Ser/Plas:Qn


name: Glucose^3rd specimen post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: Glucose^4.5H post 75 g glucose PO:PrThr:Pt:Urine:Ord:Test strip


name: Glucose^40M post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: Glucose^45M post 50 g lactose PO:MCnc:Pt:Ser/Plas:Qn


name: Glucose^4M post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: Glucose^4th specimen post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: Glucose^50M post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: Glucose^5th specimen post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: Glucose^6.5H post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: Glucose^6th specimen post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: Glucose^6th specimen post dose lactose:MCnc:Pt:Ser/Plas:Qn


name: Glucose^7.5H post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: Glucose^70M post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: Glucose^7H post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: Glucose^8H post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: Glucose^8M post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: Glucose^8th specimen post XXX challenge:MCnc:Pt:Dial fld prt:Qn


name: Glucose^9H post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: Glucose^9th specimen post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: Glucose^pre dose lactose PO:MCnc:Pt:Ser/Plas:Qn


name: Insulin-like growth factor-I^1.5H post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: Insulin-like growth factor-I^1H post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: Insulin-like growth factor-I^30M post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: Insulin^3.5H post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: Insulin^10H post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: Insulin^11H post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: Insulin^12H post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: Insulin^15M post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: Insulin^19M post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: Insulin^22M post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: Insulin^2M post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: Insulin^2nd specimen post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: Insulin^3rd specimen post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: Insulin^4.5H post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: Insulin^40M post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: Insulin^45M post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: Insulin^4M post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: Insulin^4th specimen post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: Insulin^5.5H post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: Insulin^50M post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: Insulin^5th specimen post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: Insulin^6th specimen post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: Insulin^7.5H post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: Insulin^70M post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: Insulin^7H post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: Insulin^7th specimen post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: Insulin^8H post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: Insulin^8M post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: Insulin^8th specimen post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: Insulin^9H post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: Insulin^9th specimen post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: Insulin^15M pre XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: Insulin^30M pre XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: Insulin^7H post 75 g glucose PO:MCnc:Pt:Ser/Plas:Qn


name: Ketones^1H post XXX challenge:MCnc:Pt:Urine:SemiQn:Test strip


name: Ketones^2H post XXX challenge:MCnc:Pt:Urine:SemiQn:Test strip


name: Ketones^3H post XXX challenge:MCnc:Pt:Urine:SemiQn:Test strip


name: Lutropin^10M post XXX challenge:SCnc:Pt:Ser/Plas:Qn


name: Lutropin^15M pre XXX challenge:SCnc:Pt:Ser/Plas:Qn


name: Lutropin^20M post XXX challenge:SCnc:Pt:Ser/Plas:Qn


name: Lutropin^2nd specimen post XXX challenge:SCnc:Pt:Ser/Plas:Qn


name: Lutropin^3H post XXX challenge:SCnc:Pt:Ser/Plas:Qn


name: Lutropin^3rd specimen post XXX challenge:SCnc:Pt:Ser/Plas:Qn


name: Lutropin^40M post XXX challenge:SCnc:Pt:Ser/Plas:Qn


name: Lutropin^4th specimen post XXX challenge:SCnc:Pt:Ser/Plas:Qn


name: Lutropin^5th specimen post XXX challenge:SCnc:Pt:Ser/Plas:Qn


name: Lutropin^6th specimen post XXX challenge:SCnc:Pt:Ser/Plas:Qn


name: Lutropin^7th specimen post XXX challenge:SCnc:Pt:Ser/Plas:Qn


name: Lutropin^8th specimen post XXX challenge:SCnc:Pt:Ser/Plas:Qn


name: Lutropin^9th specimen post XXX challenge:SCnc:Pt:Ser/Plas:Qn


name: Prolactin^10M post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: Prolactin^10th specimen post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: Prolactin^15M post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: Prolactin^20M post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: Prolactin^2nd specimen post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: Prolactin^3rd specimen post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: Prolactin^45M post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: Prolactin^4th specimen post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: Prolactin^5th specimen post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: Prolactin^6th specimen post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: Prolactin^7th specimen post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: Prolactin^8th specimen post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: Prolactin^9th specimen post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: Norepinephrine^1H post XXX challenge:MCnc:Pt:Plas:Qn


name: Norepinephrine^2H post XXX challenge:MCnc:Pt:Plas:Qn


name: Norepinephrine^2nd specimen post XXX challenge:MCnc:Pt:Plas:Qn


name: Norepinephrine^3H post XXX challenge:MCnc:Pt:Plas:Qn


name: Norepinephrine^3rd specimen post XXX challenge:MCnc:Pt:Plas:Qn


name: Norepinephrine^4H post XXX challenge:MCnc:Pt:Plas:Qn


name: Norepinephrine^4th specimen post XXX challenge:MCnc:Pt:Plas:Qn


name: Norepinephrine^5th specimen post XXX challenge:MCnc:Pt:Plas:Qn


name: Norepinephrine^6th specimen post XXX challenge:MCnc:Pt:Plas:Qn


name: Norepinephrine^7th specimen post XXX challenge:MCnc:Pt:Plas:Qn


name: Oxalate^10th specimen post XXX challenge:MCnc:Pt:Urine:Qn


name: Oxalate^2nd specimen post XXX challenge:MCnc:Pt:Urine:Qn


name: Oxalate^3rd specimen post XXX challenge:MCnc:Pt:Urine:Qn


name: Oxalate^4th specimen post XXX challenge:MCnc:Pt:Urine:Qn


name: Oxalate^5th specimen post XXX challenge:MCnc:Pt:Urine:Qn


name: Oxalate^6th specimen post XXX challenge:MCnc:Pt:Urine:Qn


name: Oxalate^7th specimen post XXX challenge:MCnc:Pt:Urine:Qn


name: Oxalate^8th specimen post XXX challenge:MCnc:Pt:Urine:Qn


name: Oxalate^9th specimen post XXX challenge:MCnc:Pt:Urine:Qn


name: Progesterone^1H post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: Progesterone^2nd specimen post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: Progesterone^30M post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: Progesterone^3rd specimen post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: Progesterone^4th specimen post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: Progesterone^5th specimen post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: Progesterone^6th specimen post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: Renin^2nd specimen post XXX challenge:CCnc:Pt:Plas:Qn


name: Renin^3rd specimen post XXX challenge:CCnc:Pt:Plas:Qn


name: Renin^4th specimen post XXX challenge:CCnc:Pt:Plas:Qn


name: Renin^5th specimen post XXX challenge:CCnc:Pt:Plas:Qn


name: Renin^6th specimen post XXX challenge:CCnc:Pt:Plas:Qn


name: Renin^7th specimen post XXX challenge:CCnc:Pt:Plas:Qn


name: Renin^8th specimen post XXX challenge:CCnc:Pt:Plas:Qn


name: Somatotropin^10M post XXX challenge:SCnc:Pt:Ser/Plas:Qn


name: Somatotropin^10th specimen post XXX challenge:SCnc:Pt:Ser/Plas:Qn


name: Somatotropin^15M post XXX challenge:SCnc:Pt:Ser/Plas:Qn


name: Somatotropin^2.5H post XXX challenge:SCnc:Pt:Ser/Plas:Qn


name: Somatotropin^20M post XXX challenge:SCnc:Pt:Ser/Plas:Qn


name: Somatotropin^2nd specimen post XXX challenge:SCnc:Pt:Ser/Plas:Qn


name: Somatotropin^3rd specimen post XXX challenge:SCnc:Pt:Ser/Plas:Qn


name: Somatotropin^45M post XXX challenge:SCnc:Pt:Ser/Plas:Qn


name: Somatotropin^4th specimen post XXX challenge:SCnc:Pt:Ser/Plas:Qn


name: Somatotropin^5th specimen post XXX challenge:SCnc:Pt:Ser/Plas:Qn


name: Somatotropin^6th specimen post XXX challenge:SCnc:Pt:Ser/Plas:Qn


name: Somatotropin^7th specimen post XXX challenge:SCnc:Pt:Ser/Plas:Qn


name: Somatotropin^8th specimen post XXX challenge:SCnc:Pt:Ser/Plas:Qn


name: Somatotropin^9th specimen post XXX challenge:SCnc:Pt:Ser/Plas:Qn


name: Somatotropin^15M pre XXX challenge:SCnc:Pt:Ser/Plas:Qn


name: Testosterone^1H post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: Testosterone^3H post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: Thyrotropin^1.5H post XXX challenge:ACnc:Pt:Ser/Plas:Qn


name: Thyrotropin^10M post XXX challenge:ACnc:Pt:Ser/Plas:Qn


name: Thyrotropin^15M post XXX challenge:ACnc:Pt:Ser/Plas:Qn


name: Thyrotropin^20M post XXX challenge:ACnc:Pt:Ser/Plas:Qn


name: Thyrotropin^2H post XXX challenge:ACnc:Pt:Ser/Plas:Qn


name: Thyrotropin^2nd specimen post XXX challenge:ACnc:Pt:Ser/Plas:Qn


name: Thyrotropin^3rd specimen post XXX challenge:ACnc:Pt:Ser/Plas:Qn


name: Thyrotropin^40M post XXX challenge:ACnc:Pt:Ser/Plas:Qn


name: Thyrotropin^45M post XXX challenge:ACnc:Pt:Ser/Plas:Qn


name: Thyrotropin^45M post dose TRH IV:MCnc:Pt:Ser/Plas:Qn


name: Thyrotropin^4th specimen post XXX challenge:ACnc:Pt:Ser/Plas:Qn


name: Thyrotropin^5th specimen post XXX challenge:ACnc:Pt:Ser/Plas:Qn


name: Thyrotropin^6th specimen post XXX challenge:ACnc:Pt:Ser/Plas:Qn


name: Thyrotropin^7th specimen post XXX challenge:ACnc:Pt:Ser/Plas:Qn


name: Thyrotropin^8th specimen post XXX challenge:ACnc:Pt:Ser/Plas:Qn


name: Thyrotropin^9th specimen post XXX challenge:ACnc:Pt:Ser/Plas:Qn


name: Thyrotropin^30M pre XXX challenge:ACnc:Pt:Ser/Plas:Qn


name: T4 uptake 1 Hr post Unsp challenge [Mass/Vol]


name: Thyroxine^1H post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: Thyroxine^2nd specimen post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: Thyroxine^3rd specimen post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: Thyroxine^4th specimen post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: Thyroxine^5th specimen post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: Thyroxine^6th specimen post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: Thyroxine^7th specimen post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: Thyroxine^8th specimen post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: Thyroxine^9th specimen post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: Vasopressin^2nd specimen post XXX challenge:MCnc:Pt:Plas:Qn


name: Xylose^1.5H post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: Xylose^3H post 25 g xylose PO:MCnc:Pt:Bld:Qn


name: Xylose^3H post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: Xylose^4H post 25 g xylose PO:MCnc:Pt:Bld:Qn


name: Xylose^4H post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: Xylose^5H post 25 g xylose PO:MCnc:Pt:Bld:Qn


name: Xylose^5H post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: Acetylcholine receptor binding Ab:SCnc:Pt:Ser:Qn


name: Alpha 1 antitrypsin fecal clearance:ACnc:Pt:Ser/Plas+Stool:Qn


name: Alpha 1 antitrypsin:MCnc:Pt:Amnio fld:Qn:Nephelometry


name: Creatinine^2H post peritoneal dialysis:MCnc:Pt:Periton fld:Qn


name: Creatinine^4H post peritoneal dialysis:MCnc:Pt:Periton fld:Qn


name: Creatinine dialysis fluid clearance:VRat:Pt:Dial fld+Ser/Plas:Qn


name: Creatinine^12H post peritoneal dialysis:MCnc:Pt:Periton fld:Qn


name: Creatinine^1st specimen:MCnc:Pt:Dial fld prt:Qn


name: Creatinine^24H specimen:MCnc:Pt:Dial fld prt:Qn


name: Creatinine^2H dwell specimen:MCnc:Pt:Dial fld prt:Qn


name: Creatinine^2nd specimen:MCnc:Pt:Dial fld prt:Qn


name: Creatinine^3rd specimen:MCnc:Pt:Dial fld prt:Qn


name: Creatinine^4H dwell specimen:MCnc:Pt:Dial fld prt:Qn


name: Creatinine^4th specimen:MCnc:Pt:Dial fld prt:Qn


name: Creatinine^5th specimen:MCnc:Pt:Dial fld prt:Qn


name: Creatinine^6th specimen:MCnc:Pt:Dial fld prt:Qn


name: Creatinine^7th specimen:MCnc:Pt:Dial fld prt:Qn


name: Creatinine^8th specimen:MCnc:Pt:Dial fld prt:Qn


name: Dehydroepiandrosterone^2nd specimen post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: Dehydroepiandrosterone^3rd specimen post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: Dehydroepiandrosterone^4th specimen post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: Dehydroepiandrosterone^5th specimen post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: Dehydroepiandrosterone^6th specimen post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: Deprecated Estradiol [Mass/volume] in Serum or Plasma by MEIA


name: Deprecated Estradiol [Mass/volume] in Serum or Plasma by RIA


name: Fatty acids.very long chain:SCnc:Pt:Ser/Plas:Qn


name: Galactose 1 phosphate uridyl transferase:CCnc:Pt:Bld:Qn


name: Glucose^12H post peritoneal dialysis:MCnc:Pt:Periton fld:Qn


name: Glucose^2H post peritoneal dialysis:MCnc:Pt:Periton fld:Qn


name: Glucose^4H post peritoneal dialysis:MCnc:Pt:Periton fld:Qn


name: Deprecated Mean Glucose Bld gHb Est-aCnc


name: Glucose^15M post 100 g glucose PO:MCnc:Pt:Ser/Plas:Qn


name: Glucose^1st specimen:MCnc:Pt:Dial fld prt:Qn


name: Glucose^2H dwell specimen:MCnc:Pt:Dial fld prt:Qn


name: Glucose^2nd specimen:MCnc:Pt:Dial fld prt:Qn


name: Glucose^3rd specimen:MCnc:Pt:Dial fld prt:Qn


name: Glucose^45M post 100 g glucose PO:MCnc:Pt:Ser/Plas:Qn


name: Glucose^4H dwell specimen:MCnc:Pt:Dial fld prt:Qn


name: Glucose^4th specimen:MCnc:Pt:Dial fld prt:Qn


name: Glucose^5th specimen:MCnc:Pt:Dial fld prt:Qn


name: Glucose^6th specimen:MCnc:Pt:Dial fld prt:Qn


name: Glucose^7th specimen:MCnc:Pt:Dial fld prt:Qn


name: Glucose^pre dialysis:MCnc:Pt:Dial fld prt:Qn


name: Glyceraldehyde 3 phosphate dehydrogenase:CCnc:Pt:RBC:Qn


name: Insulin-like growth factor binding protein 1:MCnc:Pt:Ser/Plas:Qn


name: Insulin-like growth factor binding protein 2:MCnc:Pt:Ser/Plas:Qn


name: Protein^2nd specimen:MCnc:Pt:Dial fld prt:Qn


name: Protein^3rd specimen:MCnc:Pt:Dial fld prt:Qn


name: Protein^4th specimen:MCnc:Pt:Dial fld prt:Qn


name: Protein^5th specimen:MCnc:Pt:Dial fld prt:Qn


name: Protein^6th specimen:MCnc:Pt:Dial fld prt:Qn


name: Protein^7th specimen:MCnc:Pt:Dial fld prt:Qn


name: Protein^8th specimen:MCnc:Pt:Dial fld prt:Qn


name: Deprecated Insulin-Like growth factor-I [Mass/volume] in Serum or Plasma


name: Deprecated Sulfate-3-Glucuronyl paragloboside Ab in serum


name: Deprecated Sulfate-3-Glucuronyl paragloboside Ab.IgM in CSF


name: Deprecated Sulfate-3-Glucuronyl paragloboside Ab.IgM in serum


name: 11-Dehydro thromboxane beta 2:MRat:24H:Urine:Qn


name: Thyrotropin:ACnc:Pt:Ser/Plas:Qn:Detection limit <= 0.005 mIU/L


name: Thyrotropin:ACnc:Pt:Ser/Plas:Qn:Detection limit <= 0.05 mIU/L


name: Triiodothyronine^2nd specimen post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: Triiodothyronine^3rd specimen post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: Triiodothyronine^4th specimen post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: Triiodothyronine^5th specimen post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: Triiodothyronine^6th specimen post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: Triiodothyronine^7th specimen post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: Triiodothyronine^8th specimen post XXX challenge:MCnc:Pt:Ser/Plas:Qn


name: Deprecated Epstein Barr virus early restricted Ab [Mass/volume] in Body fluid


name: Urea nitrogen^12H post peritoneal dialysis:MCnc:Pt:Periton fld:Qn


name: Urea nitrogen^2H post peritoneal dialysis:MCnc:Pt:Periton fld:Qn


name: Urea nitrogen^4H post peritoneal dialysis:MCnc:Pt:Periton fld:Qn


name: Urea nitrogen renal clearance:VRat:Pt:Urine+Ser/Plas:Qn


name: Urea nitrogen^post dialysis/pre dialysis:MRto:Pt:Dial fld prt:Qn


name: Urea nitrogen^1st specimen:MCnc:Pt:Dial fld prt:Qn


name: Urea nitrogen^24H specimen:MCnc:Pt:Dial fld prt:Qn


name: Urea nitrogen^2H dwell specimen:MCnc:Pt:Dial fld prt:Qn


name: Urea nitrogen^3rd specimen:MCnc:Pt:Dial fld prt:Qn


name: Urea nitrogen^4H specimen:MCnc:Pt:Dial fld:Qn


name: Urea nitrogen^4H dwell specimen:MCnc:Pt:Dial fld prt:Qn


name: Urea nitrogen^4th specimen:MCnc:Pt:Dial fld prt:Qn


name: Urea nitrogen^5th specimen:MCnc:Pt:Dial fld prt:Qn


name: Urea nitrogen^6th specimen:MCnc:Pt:Dial fld prt:Qn


name: Urea nitrogen^7th specimen:MCnc:Pt:Dial fld prt:Qn


name: Urea nitrogen^8th specimen:MCnc:Pt:Dial fld prt:Qn


name: Urea nitrogen^baseline:MCnc:Pt:Dial fld prt:Qn


name: Coagulation surface induced^2nd specimen:Time:Pt:PPP:Qn:Coag


name: Coagulation surface induced^3rd specimen:Time:Pt:PPP:Qn:Coag


name: Coagulation surface induced^4th specimen:Time:Pt:PPP:Qn:Coag


name: Protein C/Coagulation factor IX:MRto:Pt:PPP:Qn


name: Deprecated Protein S [Units/volume] in Platelet poor plasma


name: Protein S/Coagulation factor IX:MRto:Pt:PPP:Qn:Coag


name: Microscopic observation:Prid:Pt:Body fld:Nom:Cyto stain


name: Microscopic observation:Prid:Pt:Gast fld:Nom:Cyto stain


name: 3 methoxy O desmethylencainide:MCnc:Pt:Ser/Plas:Qn


name: Deprecated Nordoxepin [Mass/volume] in Serum or Plasma


name: Deprecated Normethsuximide [Mass/volume] in Serum or Plasma


name: Complement C1q Ag:ACnc:Pt:Ser/Plas:Qn:Raji cell assay


name: Complement alternate pathway AH50:ACnc:Pt:Ser/Plas:Qn


name: Complement total hemolytic CH100:ACnc:Pt:Ser/Plas:Qn


name: Hemoglobin A region:PrThr:Pt:Bld:Ord:Electrophoresis pH 8.9


name: Hemoglobin C+E+O+A2 region:PrThr:Pt:Bld:Ord:Electrophoresis pH 8.9


name: Hemoglobin S+D+G region:PrThr:Pt:Bld:Ord:Electrophoresis pH 8.9


name: Leukocytes^^corrected for nucleated erythrocytes:NCnc:Pt:Bld:Qn


name: Erythrocyte mean corpuscular volume:EntVol:Pt:BldCo:Qn:Automated count


name: Aspergillus fumigatus 1 Ab:PrThr:Pt:Ser:Ord


name: Aspergillus fumigatus 6 Ab:PrThr:Pt:Ser:Ord


name: Aspergillus niger Ab:PrThr:Pt:Ser:Ord:Immune diffusion


name: Bacillus anthracis:PrThr:Pt:XXX:Ord:Organism specific culture


name: Borrelia burgdorferi:PrThr:Pt:XXX:Ord:Organism specific culture


name: Borrelia burgdorferi 18kD Ab:PrThr:Pt:CSF:Ord:IB


name: Borrelia burgdorferi 18kD Ab:PrThr:Pt:Body fld:Ord:IB


name: Borrelia burgdorferi 25kD Ab:PrThr:Pt:CSF:Ord:IB


name: Borrelia burgdorferi 25kD Ab:PrThr:Pt:Body fld:Ord:IB


name: Borrelia burgdorferi 25kD Ab:PrThr:Pt:Ser:Ord:IB


name: Borrelia burgdorferi 29kD Ab:PrThr:Pt:CSF:Ord:IB


name: Borrelia burgdorferi 29kD Ab:PrThr:Pt:Body fld:Ord:IB


name: Borrelia burgdorferi 29kD Ab:PrThr:Pt:Ser:Ord:IB


name: Borrelia burgdorferi 30kD Ab:PrThr:Pt:CSF:Ord:IB


name: Borrelia burgdorferi 30kD Ab:PrThr:Pt:Body fld:Ord:IB


name: Borrelia burgdorferi 30kD Ab:PrThr:Pt:Ser:Ord:IB


name: Borrelia burgdorferi 39kD Ab:PrThr:Pt:CSF:Ord:IB


name: Borrelia burgdorferi 39kD Ab:PrThr:Pt:Body fld:Ord:IB


name: Borrelia burgdorferi 41kD Ab:PrThr:Pt:CSF:Ord:IB


name: Borrelia burgdorferi 41kD Ab:PrThr:Pt:Body fld:Ord:IB


name: Borrelia burgdorferi 41kD Ab:PrThr:Pt:Ser:Ord:IB


name: Borrelia burgdorferi 45kD Ab:PrThr:Pt:Ser:Ord:IB


name: Borrelia burgdorferi 47kD Ab:PrThr:Pt:CSF:Ord:IB


name: Borrelia burgdorferi 47kD Ab:PrThr:Pt:Body fld:Ord:IB


name: Borrelia burgdorferi 47kD Ab:PrThr:Pt:Ser:Ord:IB


name: Borrelia burgdorferi 58kD Ab:PrThr:Pt:CSF:Ord:IB


name: Borrelia burgdorferi 58kD Ab:PrThr:Pt:Body fld:Ord:IB


name: Borrelia burgdorferi 58kD Ab:PrThr:Pt:Ser:Ord:IB


name: Borrelia burgdorferi 66kD Ab:PrThr:Pt:CSF:Ord:IB


name: Borrelia burgdorferi 66kD Ab:PrThr:Pt:Body fld:Ord:IB


name: Borrelia burgdorferi 88kD Ab:PrThr:Pt:CSF:Ord:IB


name: Borrelia burgdorferi 88kD Ab:PrThr:Pt:Body fld:Ord:IB


name: Borrelia burgdorferi 88kD Ab:PrThr:Pt:Ser:Ord:IB


name: Borrelia burgdorferi 93kD Ab:PrThr:Pt:Ser:Ord:IB


name: Borrelia burgdorferi Ab band pattern:Imp:Pt:Ser:Nom:IB


name: Borrelia burgdorferi Ab.IgG:PrThr:Pt:Synv fld:Ord:IB


name: Borrelia burgdorferi Ab.IgG band pattern:Imp:Pt:Ser:Nom:IB


name: Borrelia burgdorferi Ab.IgM:PrThr:Pt:Synv fld:Ord:IB


name: Borrelia burgdorferi Ab.IgM band pattern:Imp:Pt:Ser:Nom:IB


name: Borrelia burgdorferi DNA:PrThr:Pt:Body fld:Ord:Probe.amp


name: Chlamydia trachomatis B Ab:ACnc:Pt:Ser:Qn


name: Chlamydia trachomatis C Ab.IgM:ACnc:Pt:Ser:Qn


name: Chlamydia trachomatis C Ab:ACnc:Pt:Ser:Qn


name: Chlamydia trachomatis G+F+K Ab.IgM:ACnc:Pt:Ser:Qn


name: Chlamydia trachomatis G+F+K Ab:ACnc:Pt:Ser:Qn


name: Clostridioides difficile toxin B:PrThr:Pt:Stool:Ord


name: Colorado tick fever virus Ab.IgG:ACnc:Pt:Ser:Qn


name: Colorado tick fever virus Ab.IgM:ACnc:Pt:Ser:Qn


name: Eastern equine encephalitis virus Ab.IgG:ACnc:Pt:CSF:Qn


name: Eastern equine encephalitis virus Ab.IgG:Titr:Pt:CSF:SemiQn:IF


name: Eastern equine encephalitis virus Ab.IgG:Titr:Pt:Ser:SemiQn:IF


name: Eastern equine encephalitis virus Ab.IgM:ACnc:Pt:CSF:Qn


name: Eastern equine encephalitis virus Ab.IgM:Titr:Pt:CSF:SemiQn:IF


name: Eastern equine encephalitis virus Ab.IgM:Titr:Pt:Ser:SemiQn:IF


name: Enterococcus species.vancomycin resistant:PrThr:Pt:XXX:Ord:Organism specific culture


name: Epstein Barr virus early diffuse Ab:PrThr:Pt:Ser:Ord:IF


name: Epstein Barr virus early restricted Ab:PrThr:Pt:Ser:Ord:IF


name: Epstein Barr virus nuclear Ab.IgG:Titr:Pt:Ser:SemiQn:IF


name: Epstein Barr virus capsid Ab.IgG:Titr:Pt:CSF:SemiQn:IF


name: Epstein Barr virus capsid Ab.IgM:Titr:Pt:CSF:SemiQn:IF


name: Escherichia coli enteroinvasive identified:Prid:Pt:Stool:Nom:Organism specific culture


name: Escherichia coli labile toxin:PrThr:Pt:XXX:Ord


name: Deprecated Escherichia coli O157:H7 identified in Stool by Organism specific culture


name: Escherichia coli O157:H7:PrThr:Pt:Stool:Ord:Organism specific culture


name: Haemophilus ducreyi:PrThr:Pt:XXX:Ord:Organism specific culture


name: Haemophilus influenzae B Ab.IgG:MCnc:Pt:Ser:Qn


name: Haemophilus influenzae B Ab:ACnc:Pt:Ser:Qn


name: Haemophilus influenzae B Ab.IgG:MCnc:Pt:Ser:Qn:IA


name: Hepatitis B virus surface Ab:PrThr:Pt:Ser:Ord:IA


name: Hepatitis C virus 5-1-1 Ab:PrThr:Pt:Ser:Ord:IB


name: Hepatitis C virus superoxide dismutase Ab:PrThr:Pt:Ser:Ord:IB


name: Hepatitis C virus RNA:ACnc:Pt:Ser/Plas:Qn:Probe.amp.tar


name: Hepatitis C virus RNA:PrThr:Pt:Ser/Plas:Ord:Probe.amp.tar


name: Herpes simplex virus 1+2 Ab pattern:Imp:Pt:Ser:Nom


name: Herpes simplex virus 1+2 Ab.IgG:ACnc:Pt:CSF:Qn


name: Herpes simplex virus 2 Ab pattern:Imp:Pt:Ser:Nom


name: Herpes simplex virus 1 Ab:ACnc:Pt:Ser:Qn:IF


name: Herpes simplex virus 1 Ab.IgM:ACnc:Pt:CSF:Qn


name: Herpes simplex virus 2 Ab:ACnc:Pt:Ser:Qn:IF


name: Herpes simplex virus 2 Ab.IgM:ACnc:Pt:CSF:Qn


name: Herpes virus 6 Ab.IgG+IgM:ACnc:Pt:Ser:Qn


name: Histoplasma capsulatum mycelial phase Ab:PrThr:Pt:CSF:Ord


name: Histoplasma capsulatum yeast phase Ab:PrThr:Pt:CSF:Ord


name: Hydatid cyst identified:Prid:Pt:XXX:Nom:Wet preparation


name: Isospora belli:PrThr:Pt:XXX:Ord:Acid fast stain.Kinyoun modified


name: Japanese encephalitis virus Ab:ACnc:Pt:Ser:Qn


name: La Crosse virus Ab.IgG:Titr:Pt:Ser:SemiQn:IF


name: La Crosse virus Ab.IgM:Titr:Pt:Ser:SemiQn:IF


name: Legionella longbeachae 1+2 Ab:PrThr:Pt:Ser:Ord


name: Legionella non pneumophila sp Ab:PrThr:Pt:Ser:Ord


name: Legionella pneumophila atypical Ab:PrThr:Pt:Ser:Ord


name: Lymphocytic choriomeningitis virus Ab:ACnc:Pt:Ser:Qn


name: Microfilaria sp identified Concentration Nom (Bld)


name: Ova & parasites identified:Prid:Pt:Duod fld/Gast fld:Nom:Microscopy.light


name: Microscopic observation:Prid:Pt:Gast fld:Nom:Acid fast stain


name: Microscopic observation:Prid:Pt:Genital muc:Nom:Gram stain


name: Microscopic observation:Prid:Pt:Sputum:Nom:Acid fast stain


name: Microscopic observation:Prid:Pt:Stool:Nom:Acid fast stain


name: Microscopic observation:Prid:Pt:Tiss:Nom:Acid fast stain


name: Microscopic observation:Prid:Pt:Urine:Nom:Acid fast stain


name: Microscopic observation:Prid:Pt:XXX:Nom:Acid fast stain


name: Ova & parasites identified^2nd specimen:Prid:Pt:Stool:Nom:Microscopy.light


name: Ova & parasites identified^3rd specimen:Prid:Pt:Stool:Nom:Microscopy.light


name: Mycoplasma pneumoniae Ab^1st specimen:ACnc:Pt:Ser:Qn


name: Mycoplasma pneumoniae Ab^2nd specimen:ACnc:Pt:Ser:Qn


name: Neisseria meningitidis serogroup A Ab:ACnc:Pt:Ser:Qn


name: Neisseria meningitidis serogroup C Ab:ACnc:Pt:Ser:Qn


name: Human papilloma virus Ab.IgG:PrThr:Pt:Ser:Ord


name: Human papilloma virus Ab.IgM:PrThr:Pt:Ser:Ord


name: Human papilloma virus Ag:PrThr:Pt:Genital:Ord


name: Human papilloma virus 16+18 Ag:PrThr:Pt:Genital:Ord


name: Human papilloma virus identified:Prid:Pt:Cvx:Nom


name: Human papilloma virus identified:Prid:Pt:XXX:Nom


name: Parainfluenza virus 3 Ab.IgG:Titr:Pt:Ser:SemiQn


name: Parainfluenza virus 3 Ab.IgM:Titr:Pt:Ser:SemiQn


name: Rubella virus Ab.IgG^1st specimen:ACnc:Pt:Ser:Qn


name: Rubella virus Ab.IgG^2nd specimen:ACnc:Pt:Ser:Qn


name: Saint Louis encephalitis virus Ab.IgG:ACnc:Pt:CSF:Qn


name: Saint Louis encephalitis virus Ab.IgG:Titr:Pt:Ser:SemiQn:IF


name: Saint Louis encephalitis virus Ab.IgM:ACnc:Pt:CSF:Qn


name: Saint Louis encephalitis virus Ab.IgM:Titr:Pt:Ser:SemiQn:IF


name: Salmonella paratyphi A Ab:PrThr:Pt:Ser:Ord:Aggl


name: Salmonella paratyphi B Ab:PrThr:Pt:Ser:Ord:Aggl


name: Salmonella typhi H D Ab:PrThr:Pt:Ser:Ord


name: Staphylococcus aureus.methicillin resistant isolate:PrThr:Pt:XXX:Ord:Organism specific culture


name: Streptococcus pneumoniae 12 Ab:ACnc:Pt:Ser:Qn


name: Streptococcus pneumoniae Danish serotype 18C Ab:ACnc:Pt:Ser:Qn


name: Deprecated Streptococcus pneumoniae 19 Ab [Units/volume] in Serum (13137-5)


name: Streptococcus pneumoniae 23 Ab:ACnc:Pt:Ser:Qn


name: Streptococcus pneumoniae Danish serotype 7F Ab:ACnc:Pt:Ser:Qn


name: Streptococcus pneumoniae Danish serotype 6B Ab:ACnc:Pt:Ser:Qn


name: Streptococcus pneumoniae Danish serotype 7F Ab^2nd specimen:ACnc:Pt:Ser:Qn


name: Streptococcus pyogenes:PrThr:Pt:Thrt:Ord:Organism specific culture


name: Streptococcus pyogenes enzyme Ab:PrThr:Pt:Ser:Ord:Sheep cell aggl


name: Toxoplasma gondii Ab.IgG^2nd specimen:ACnc:Pt:Ser:Qn


name: Trypanosoma sp:Prid:Pt:Bld:Nom:Acridine orange and Giemsa stain


name: Varicella zoster virus Ab:PrThr:Pt:Ser:Ord:LA


name: Varicella zoster virus:PrThr:Pt:XXX:Ord:Organism specific culture


name: Varicella zoster virus DNA:PrThr:Pt:XXX:Ord:Probe.amp.tar


name: Viral inclusion bodies:Prid:Pt:XXX:Nom:Cyto stain


name: Acetylcholine receptor binding Ab:ACnc:Pt:Ser:Qn


name: Acetylcholine receptor blocking Ab:ACnc:Pt:Ser:Qn


name: Acetylcholine receptor modulation Ab:ACnc:Pt:Ser:Qn


name: Bovine inner ear Ag:PrThr:Pt:Ser/Plas:Ord:IB


name: Voltage-gated calcium channel Ab.IgG:ACnc:Pt:Ser:Qn


name: Deprecated Disialylganglioside GD1b Ab in serum


name: DNA double strand Ab:PrThr:Pt:Ser:Ord:Farr


name: Heterophile Ab:PrThr:Pt:Ser:Ord:Sheep cell aggl


name: Immune complex:ACnc:Pt:Ser/Plas:Qn:Raji cell assay


name: Jo-1 extractable nuclear Ab:ACnc:Pt:Ser:Qn


name: Liver kidney microsomal Ab:ACnc:Pt:Ser:Qn


name: Mucin-like carcinoma associated Ag:ACnc:Pt:Ser/Plas:Qn


name: Myelin associated glycoprotein Ab:PrThr:Pt:CSF:Ord:IB


name: Myelin associated glycoprotein Ab:PrThr:Pt:Ser:Ord:IB


name: Deprecated Myelin associated glycoprotein Ab.IgM in serum


name: Neuronal nuclear type 1 Ab:ACnc:Pt:Ser:Qn


name: Deprecated Nuclear Ab by Immunofluorescence


name: Deprecated Nuclear Ab Immunofluorescence (rat kidney substrate)


name: Nuclear Ab pattern:Imp:Pt:Body fld:Nom:IF


name: Rheumatoid arthritis nuclear Ab:ACnc:Pt:Ser:Qn


name: RNA polymerase I+II+III Ab:PrThr:Pt:Ser:Ord


name: Smith extractable nuclear Ab:ACnc:Pt:Ser:Qn


name: Deprecated Tetrasialylganglioside GQ1b Ab in serum


name: Microscopic observation:Prid:Pt:Bld/Bone mar:Nom:Esterase stain.non-specific


name: Microscopic observation:Prid:Pt:Bld/Bone mar:Nom:Chloracetate esterase stain


name: Microscopic observation:Prid:Pt:Bld/Bone mar:Nom:Peroxidase stain


name: Microscopic observation:Prid:Pt:Bld/Bone mar:Nom:Sudan black B stain


name: Microscopic observation:Prid:Pt:Bld/Bone mar:Nom:Tartrate-resistant acid phosphatase stain


name: Microscopic observation:Prid:Pt:Bld/Bone mar:Nom:Terminal deoxynucleotidyl transferase stain


name: Albumin:MCnc:Pt:Urine:SemiQn:Detection limit <= 20 mg/L test strip


name: Calcium hydrogen phosphate dihydrate crystals:PrThr:Pt:Urine sed:Ord:Microscopy.light


name: Eosinophils/100 leukocytes:NFr:Pt:Urine sed:Qn:Manual count


name: Urine sediment comments:Find:Pt:Urine sed:Nar:Microscopy.light


name: Body temperature measurement site:Anat:Enctr^frst:XXX:Nom


name: Acuity assessment practitioner identification:Type:Pt:Provider:Nom


name: Acuity assessment practitioner profession:Type:Pt:Provider:Nom


name: ED clinical finding practitioner ID:ID:Pt:Provider:Nom


name: ED clinical finding practitioner profession:Type:Pt:Provider:Nom


name: ED consultant practitioner ID:ID:Pt:Provider:Nom


name: ED consultant practitioner profession:Type:Pt:Provider:Nom


name: ED disposition consult &or referral:Type:Pt:^Patient:Nom


name: ED disposition diagnosis practitioner identification:Type:Pt:Provider:Nom


name: ED disposition diagnosis practitioner profession:Type:Pt:Provider:Nom


name: ED medication practitioner identification:Type:Pt:Provider:Nom


name: ED medication practitioner profession:Type:Pt:Provider:Nom


name: ED outcome observation practitioner identification:Type:Pt:Provider:Nom


name: ED outcome observation practitioner profession:Type:Pt:Provider:Nom


name: ED patient satisfaction report type:Type:Pt:^Patient:Nom


name: ED procedure practitioner profession:Type:Pt:Provider:Nom


name: ED procedure practitioner ID:ID:Pt:Provider:Nom


name: ED procedure result observation:Imp:Pt:^Patient:Nom


name: ED procedure result type:Type:Pt:^Patient:Nom


name: ED service level practitioner profession:Type:Pt:Provider:Nom


name: ED service level practitioner identification:Type:Pt:Provider:Nom


name: Ambulance transport agency:ID:Pt:EMS system:Nom


name: Ambulance transport unit:ID:Pt:EMS system:Nom


name: Glasgow coma score.eye opening:Fcn:Enctr^frst:^Patient:Ord


name: History and physical note:Find:Pt:Hospital:Doc:{Role}


name: Alcohol binge episodes per M:NRat:1Mo:^Patient:Qn:Reported


name: Alcoholic drinks per drinking D:NRat:1D:^Patient:Qn:Reported


name: Feeding and dietary status:Find:Pt:^Patient:Nar:Reported


name: Feeding and dietary status:Find:Pt:^Patient:Nom:Reported


name: Major illnesses and injuries:Hx:Pt:^Patient:Nar


name: Major illnesses and injuries:Hx:Pt:^Patient:Nom


name: Other nonmedical drug use:Hx:Pt:^Patient:Nar


name: Other nonmedical drug use:Hx:Pt:^Patient:Nom


name: Symptoms & diseases:Hx:Pt:Allergic & Immunologic:Nar


name: Symptoms & diseases:Hx:Pt:Allergic & Immunologic:Nom


name: Symptoms & diseases:Hx:Pt:Ears & Nose & Sinuses & Mouth & Thr:Nar


name: Symptoms & diseases:Hx:Pt:Ears & Nose & Sinuses & Mouth & Thr:Nom


name: Symptoms & diseases:Hx:Pt:Gastrointestinal system:Nar


name: Symptoms & diseases:Hx:Pt:Gastrointestinal system:Nom


name: Symptoms & diseases:Hx:Pt:Genitourinary systems:Nar


name: Symptoms & diseases:Hx:Pt:Genitourinary systems:Nom


name: Symptoms & diseases:Hx:Pt:Integumentary system:Nar


name: Symptoms & diseases:Hx:Pt:Integumentary system:Nom


name: Hospital discharge studies summary:Find:Pt:^Patient:Nar


name: Illness or injury onset date and time:TmStp:Pt:^Patient:Qn


name: Initial visit for chief complaint:Type:Pt:^Patient:Nom


name: Labor and delivery records:Finding:-:^Patient:Document


name: Marital status and living arrangements:Find:Pt:^Patient:Nar:Reported


name: Marital status and living arrangements:Find:Pt:^Patient:Nom:Reported


name: Deprecated Review of symptoms and diseases: Find: Pt: ^Patient: Nar: Reported


name: Deprecated Review of symptoms and diseases: Find: Pt: ^Patient: Nom: Reported


name: Clostridium tetani immunization status:Hx:Pt:^Patient:Nom


name: Physical examination by organ systems:Find:Pt:^Patient:Nom:Observed


name: Physical findings:Find:Pt:Ears & Nose & Mouth & Throat:Nar:Observed


name: Physical findings:Find:Pt:Ears & Nose & Mouth & Throat:Nom:Observed


name: Episode of care medical records:Find:Pt:^Patient:Doc:Chiropractic


name: Episode of care medical records:Find:Pt:^Patient:Doc:Occupational therapy


name: Episode of care medical records:Find:Pt:^Patient:Doc:Physical therapy


name: Episode of care medical records:Find:Pt:^Patient:Doc:Physician


name: Episode of care medical records:Find:Pt:^Patient:Doc:Podiatry


name: Episode of care medical records:Find:Pt:^Patient:Doc:Psychology


name: Episode of care medical records:Find:Pt:^Patient:Doc:Social service


name: Episode of care medical records:Find:Pt:^Patient:Doc:Speech therapy


name: Notes:Finding:Duration of an encounter:^Patient:Document:Nursing


name: Deprecated Radiology Unspecified site and modality Study


name: Surgical pathology study:Find:Pt:^Patient:Doc:Surgical pathology


name: Amniotic fluid index:Len:Pt:Am fld space.quadrant four^Fetus:Qn:US.derived


name: Amniotic fluid index:Len:Pt:Am fld space.quadrant one^Fetus:Qn:US.derived


name: Amniotic fluid index:Len:Pt:Am fld space.quadrant three^Fetus:Qn:US.derived


name: Amniotic fluid index:Len:Pt:Am fld space.quadrant two^Fetus:Qn:US.derived


name: Amniotic fluid index.sum:Len:Pt:Am fld space^Fetus:Qn:US.derived


name: Binocular distance:Len:Pt:Head^Fetus:Qn:US+Estimated from BPD


name: Biophysical profile.amniotic fluid volume:Fcn:Pt:^Fetus:Ord:US


name: Deprecated Mitral valve Blood flow.diastolic.atrial wave.max by US.doppler


name: E wave/A wave:VelRto:Pt:Mitral valve^Fetus:Qn:US.doppler


name: E wave/A wave:VelRto:Pt:Tricuspid valve^Fetus:Qn:US.doppler


name: Blood flow velocity.diastolic.end:Vel:Pt:{Circulatory system}:Qn:US.doppler


name: Blood flow velocity.diastolic.min:Vel:Pt:Cerebral artery anterior^Fetus:Qn:US.doppler


name: Blood flow velocity.diastolic.min:Vel:Pt:Cerebral artery anterior:Qn:US.doppler


name: Blood flow velocity.diastolic.min:Vel:Pt:Cerebral artery middle^Fetus:Qn:US.doppler


name: Blood flow velocity.diastolic.min:Vel:Pt:Cerebral artery middle:Qn:US.doppler


name: Blood flow velocity.diastolic.min:Vel:Pt:Ovarian artery.left:Qn:US.doppler


name: Blood flow velocity.diastolic.min:Vel:Pt:Ovarian artery.right:Qn:US.doppler


name: Blood flow velocity.diastolic.min:Vel:Pt:Umbilical artery.at fetus^Fetus:Qn:US.doppler


name: Blood flow velocity.diastolic.min:Vel:Pt:Umbilical artery.at placenta^Fetus:Qn:US.doppler


name: Blood flow velocity.diastolic.min:Vel:Pt:Umbilical artery.between fetus and placenta^Fetus:Qn:US.doppler


name: Blood flow velocity.diastolic.min:Vel:Pt:Uterine artery.left:Qn:US.doppler


name: Blood flow velocity.diastolic.min:Vel:Pt:Uterine artery.right:Qn:US.doppler


name: Blood flow velocity.diastolic.min:Vel:Pt:{Circulatory system}:Qn:US.doppler


name: Blood flow velocity.mean:Vel:Pt:Aorta ascending^Fetus:Qn:US.doppler


name: Blood flow velocity.mean:Vel:Pt:Aorta ascending:Qn:US.doppler


name: Blood flow velocity.mean:Vel:Pt:Aorta descending^Fetus:Qn:US.doppler


name: Blood flow velocity.mean:Vel:Pt:Aorta descending:Qn:US.doppler


name: Blood flow velocity.mean:Vel:Pt:Aortic arch^Fetus:Qn:US.doppler


name: Blood flow velocity.mean:Vel:Pt:Aortic arch:Qn:US.doppler


name: Blood flow velocity.mean:Vel:Pt:Cerebral artery anterior^Fetus:Qn:US.doppler


name: Blood flow velocity.mean:Vel:Pt:Cerebral artery anterior:Qn:US.doppler


name: Blood flow velocity.mean:Vel:Pt:Cerebral artery middle:Qn:US.doppler


name: Blood flow velocity.mean:Vel:Pt:Ductus arteriosus^Fetus:Qn:US.doppler


name: Blood flow velocity.mean:Vel:Pt:Ductus arteriosus:Qn:US.doppler


name: Blood flow velocity.mean:Vel:Pt:Pulmonic valve^Fetus:Qn:US.doppler


name: Blood flow velocity.mean:Vel:Pt:Pulmonic valve:Qn:US.doppler


name: Blood flow velocity.mean:Vel:Pt:Heart.ventricle.left.outflow tract^Fetus:Qn:US.doppler


name: Deprecated Left ventricular outflow tract Mean blood flow Doppler.measured


name: Blood flow velocity.mean:Vel:Pt:Heart.ventricle.right.outflow tract^Fetus:Qn:US.doppler


name: Deprecated Right ventricular outflow tract Mean blood flow Doppler.measured


name: Blood flow velocity.mean:Vel:Pt:Ovarian artery.left:Qn:US.doppler


name: Blood flow velocity.mean:Vel:Pt:Ovarian artery.right:Qn:US.doppler


name: Blood flow velocity.mean:Vel:Pt:Pulmonary artery.main^Fetus:Qn:US.doppler


name: Blood flow velocity.mean:Vel:Pt:Pulmonary artery.main:Qn:US.doppler


name: Blood flow velocity.mean:Vel:Pt:Umbilical artery.at fetus^Fetus:Qn:US.doppler


name: Blood flow.mean:Vel:Pt:Umbilical artery.at placenta^Fetus:Qn:US.doppler


name: Blood flow.mean:Vel:Pt:Umbilical artery.between fetus and placenta^Fetus:Qn:US.doppler


name: Blood flow velocity.mean.max:Vel:Pt:{Circulatory system}:Qn:US.doppler


name: Blood flow velocity.systolic.max:Vel:Pt:Aorta ascending^Fetus:Qn:US.doppler


name: Blood flow velocity.systolic.max:Vel:Pt:Aorta ascending:Qn:US.doppler


name: Blood flow velocity.systolic.max:Vel:Pt:Aorta descending^Fetus:Qn:US.doppler


name: Blood flow velocity.systolic.max:Vel:Pt:Aorta descending:Qn:US.doppler


name: Blood flow velocity.systolic.max:Vel:Pt:Aortic arch^Fetus:Qn:US.doppler


name: Blood flow velocity.systolic.max:Vel:Pt:Aortic arch:Qn:US.doppler


name: Blood flow velocity.systolic.max:Vel:Pt:Cerebral artery anterior^Fetus:Qn:US.doppler


name: Blood flow velocity.systolic.max:Vel:Pt:Cerebral artery anterior:Qn:US.doppler


name: Blood flow velocity.systolic.max:Vel:Pt:Cerebral artery middle^Fetus:Qn:US.doppler


name: Blood flow velocity.systolic.max:Vel:Pt:Cerebral artery middle:Qn:US.doppler


name: Blood flow velocity.systolic.max:Vel:Pt:Ductus arteriosus^Fetus:Qn:US.doppler


name: Blood flow velocity.systolic.max:Vel:Pt:Ductus arteriosus:Qn:US.doppler


name: Blood flow velocity.systolic.max:Vel:Pt:Aortic valve^Fetus:Qn:US.doppler


name: Blood flow velocity.systolic.max:Vel:Pt:Mitral valve^Fetus:Qn:US.doppler


name: Blood flow velocity.systolic.max:Vel:Pt:Mitral valve:Qn:US.doppler


name: Blood flow velocity.systolic.max:Vel:Pt:Pulmonic valve^Fetus:Qn:US.doppler


name: Blood flow velocity.systolic.max:Vel:Pt:Pulmonic valve:Qn:US.doppler


name: Blood flow velocity.systolic.max:Vel:Pt:Tricuspid valve^Fetus:Qn:US.doppler


name: Blood flow velocity.systolic.max:Vel:Pt:Tricuspid valve:Qn:US.doppler


name: Blood flow velocity.systolic.max:Vel:Pt:Heart.ventricle.left.outflow tract^Fetus:Qn:US.doppler


name: Blood flow velocity.systolic.max:Vel:Pt:Heart.ventricle.right.outflow tract^Fetus:Qn:US.doppler


name: Blood flow velocity.systolic.max:Vel:Pt:Ovarian artery.left:Qn:US.doppler


name: Blood flow velocity.systolic.max:Vel:Pt:Ovarian artery.right:Qn:US.doppler


name: Blood flow velocity.systolic.max:Vel:Pt:Pulmonary artery.main^Fetus:Qn:US.doppler


name: Blood flow velocity.systolic.max:Vel:Pt:Pulmonary artery.main:Qn:US.doppler


name: Blood flow velocity.systolic.max:Vel:Pt:Umbilical artery.at fetus^Fetus:Qn:US.doppler


name: Blood flow velocity.systolic.max:Vel:Pt:Umbilical artery.at placenta^Fetus:Qn:US.doppler


name: Blood flow velocity.systolic.max:Vel:Pt:Umbilical artery.between fetus and placenta^Fetus:Qn:US.doppler


name: Blood flow velocity.systolic.max:Vel:Pt:Uterine artery.left:Qn:US.doppler


name: Blood flow velocity.systolic.max:Vel:Pt:Uterine artery.right:Qn:US.doppler


name: Blood flow velocity.systolic.max:Vel:Pt:{Circulatory system}:Qn:US.doppler


name: Body weight:Mass:Pt:^Fetus:Qn:US+Estimated from AC


name: Body weight:Mass:Pt:^Fetus:Qn:US+Estimated from AC&BPD


name: Body weight:Mass:Pt:^Fetus:Qn:US+Estimated from AC&BPD&FL


name: Body weight:Mass:Pt:^Fetus:Qn:US+Estimated from AC&BPD&FL&HC


name: Body weight:Mass:Pt:^Fetus:Qn:US+Estimated from AC&BPD&FL&HC.Hadlock 1985


name: Body weight:Mass:Pt:^Fetus:Qn:US+Estimated from AC&BPD&FL&HC.Roberts 1985


name: Body weight:Mass:Pt:^Fetus:Qn:US+Estimated from AC&BPD&FL.Hadlock 1984


name: Body weight:Mass:Pt:^Fetus:Qn:US+Estimated from AC&BPD&FL.Hadlock 1985